ANS is committed to advancing, fostering, and promoting the development and application of nuclear sciences and technologies to benefit society.
Explore the many uses for nuclear science and its impact on energy, the environment, healthcare, food, and more.
Explore membership for yourself or for your organization.
Conference Spotlight
Nuclear Energy Conference & Expo (NECX)
September 8–11, 2025
Atlanta, GA|Atlanta Marriott Marquis
Standards Program
The Standards Committee is responsible for the development and maintenance of voluntary consensus standards that address the design, analysis, and operation of components, systems, and facilities related to the application of nuclear science and technology. Find out What’s New, check out the Standards Store, or Get Involved today!
Latest Magazine Issues
Jul 2025
Jan 2025
Latest Journal Issues
Nuclear Science and Engineering
August 2025
Nuclear Technology
Fusion Science and Technology
July 2025
Latest News
Hash Hashemian: Visionary leadership
As Dr. Hashem M. “Hash” Hashemian prepares to step into his term as President of the American Nuclear Society, he is clear that he wants to make the most of this unique moment.
A groundswell in public approval of nuclear is finding a home in growing governmental support that is backed by a tailwind of technological innovation. “Now is a good time to be in nuclear,” Hashemian said, as he explained the criticality of this moment and what he hoped to accomplish as president.
J. Coulot, F. Lavielle, A. Faggiano, N. Bellon, B. Aubert, M. Schlumberger, M. Ricard
Nuclear Science and Engineering | Volume 149 | Number 2 | February 2005 | Pages 124-130
Technical Paper | doi.org/10.13182/NSE05-A2483
Articles are hosted by Taylor and Francis Online.
Standard macroscopic methods used to assess the dose in nuclear medicine are limited to cases of homogeneous radionuclide distributions and provide dose estimations at the organ level. In a few applications, like radioimmunotherapy, the mean dose to an organ is not suitable to explain clinical observations, and knowledge of the dose at the tissular level is mandatory. Therefore, one must determine how particles lose their energy and what is the best way to represent tissues. The Monte Carlo method is appropriate to solve the problem of particle transport, but the question of the geometric representation of biology remains. In this paper, we describe a software (CLUSTER3D) that is able to build randomly biologically representative sphere cluster geometries using a statistical description of tissues. These geometries are then used by our Monte Carlo code called DOSE3D to perform particle transport. First results obtained on thyroid models highlight the need of cellular and tissular data to take into account actual radionuclide distributions in tissues. The flexibility and reliability of the method makes it a useful tool to study the energy deposition at various cellular and tissular levels in any configuration.